Holen Sie sich die Stockscreener-App
428.03
2.88%
11.99
Schlusskurs vom Vortag:
$416.04
Offen:
$421.445
24-Stunden-Volumen:
672.77K
Relative Volume:
2.35
Marktkapitalisierung:
$12.15B
Einnahmen:
$2.36B
Nettoeinkommen (Verlust:
$433.01M
KGV:
29.94
EPS:
14.2984
Netto-Cashflow:
$676.77M
1W Leistung:
-21.03%
1M Leistung:
-29.65%
6M Leistung:
-8.54%
1J Leistung:
+25.01%
1-Tages-Spanne:
$421.44
$442.41
1-Wochen-Bereich:
$392.35
$547.07
52-Wochen-Spanne:
$250.05
$628.92
Medpace Holdings Inc Stock (MEDP) Company Profile
Firmenname
Medpace Holdings Inc
Sektor
Branche
Telefon
(513) 579-9911
Adresse
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
428.03 | 11.81B | 2.36B | 433.01M | 676.77M | 14.30 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-02 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-09-03 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-29 | Herabstufung | UBS | Neutral → Sell |
| 2025-07-23 | Herabstufung | TD Cowen | Hold → Sell |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-04-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-24 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-10-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-27 | Herabstufung | UBS | Buy → Neutral |
| 2024-09-25 | Herabstufung | Jefferies | Buy → Hold |
| 2024-08-01 | Eingeleitet | Truist | Hold |
| 2024-05-29 | Eingeleitet | TD Cowen | Buy |
| 2024-05-28 | Eingeleitet | Mizuho | Buy |
| 2024-04-23 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-18 | Eingeleitet | Deutsche Bank | Hold |
| 2024-02-15 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-05-08 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-10-27 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-07 | Eingeleitet | UBS | Sell |
| 2022-05-24 | Eingeleitet | Guggenheim | Neutral |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-10-02 | Hochstufung | Truist | Hold → Buy |
| 2020-06-08 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2020-05-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-04-30 | Hochstufung | SunTrust | Sell → Hold |
| 2020-04-20 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-03-17 | Herabstufung | SunTrust | Hold → Sell |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2018-10-31 | Hochstufung | SunTrust | Hold → Buy |
| 2018-09-17 | Eingeleitet | SunTrust | Hold |
| 2018-07-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-11-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2017-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2017-07-10 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Medpace Holdings Inc Aktie (MEDP) Neueste Nachrichten
Medpace outlines 2026 revenue growth of up to 12.8% amid backlog normalization and metabolic trial shifts - MSN
Jefferies Upgrades Medpace to Buy From Hold, $560 Price Target - marketscreener.com
Prescott Group Capital Management L.L.C. Cuts Position in Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace Holdings, Inc. (NASDAQ:MEDP) Just Reported, And Analysts Assigned A US$491 Price Target - simplywall.st
Medpace (MEDP) Q4 2025 Earnings Call Transcript - AOL.com
Assessing Medpace (MEDP) Valuation After A Sharp Share Price Pullback And Backlog Concerns - Yahoo Finance
What’s the fair value of Medpace Holdings Inc. stockJuly 2025 Action & Weekly Setup with ROI Potential - mfd.ru
Krilogy Financial LLC Purchases New Holdings in Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2025 Earnings Call Transcript - Insider Monkey
Baird upgrades Medpace stock rating to Outperform on AI potential By Investing.com - Investing.com Australia
4 Analysts Have This To Say About Medpace Hldgs - Benzinga
Can Medpace Holdings Inc. continue delivering strong returns2025 Momentum Check & Long-Term Growth Portfolio Plans - mfd.ru
Baird upgrades Medpace stock rating to Outperform on AI potential - Investing.com
Deutsche Bank Adjusts Medpace Price Target to $480 From $600, Maintains Hold Rating - marketscreener.com
Truist Securities Adjusts Price Target on Medpace to $539 From $555, Maintains Hold Rating - marketscreener.com
Medpace stock price target lowered to $460 by BMO Capital - Investing.com South Africa
Medpace (NASDAQ:MEDP) Given New $500.00 Price Target at Barclays - MarketBeat
Medpace stock price target lowered to $460 by BMO Capital By Investing.com - Investing.com India
Can Medpace Holdings Inc. lead its sector in growthJuly 2025 Snapshot & Weekly High Return Opportunities - mfd.ru
Leerink Partners Issues Pessimistic Forecast for Medpace (NASDAQ:MEDP) Stock Price - MarketBeat
Medpace (NASDAQ:MEDP) Price Target Lowered to $539.00 at Truist Financial - MarketBeat
Madison Asset Management LLC Sells 4,419 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat
Candriam S.C.A. Decreases Stake in Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace Q4 2025 slides: Revenue up 32%, stock tumbles on guidance By Investing.com - Investing.com South Africa
Medpace Q4 Earnings Beat Overshadowed by Cancellation Spike - AlphaStreet News
Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial - Yahoo Finance
Decoding Medpace Holdings Inc (MEDP): A Strategic SWOT Insight - GuruFocus
Medpace (MEDP) Stock Declines Significantly - GuruFocus
Medpace Q4 2025 slides: Revenue up 32%, stock tumbles on guidance - Investing.com Nigeria
Medpace Holdings’ Earnings Call Signals Growth Amid Volatility - TipRanks
Leerink Partners lowers Medpace stock price target on elevated cancellations By Investing.com - Investing.com South Africa
Medpace (MEDP) Sees Upgrade Despite Stock Decline - GuruFocus
Leerink Partners lowers Medpace stock price target on elevated cancellations - Investing.com
Medpace Holdings Inc (MEDP) Q4 2025 Earnings Call Highlights: St - GuruFocus
U.S. Markets Ended Tuesday Mixed As Spotify Technology Led, Medpace Holdings Lagged - Barron's
Medpace Q4 Earnings Call Highlights - MarketBeat
Medpace (NASDAQ:MEDP) Raised to "Outperform" at Robert W. Baird - MarketBeat
Medpace Holdings Inc (NASDAQ:MEDP) Issues Inline Guidance - FXDailyReport.Com
Medpace (NASDAQ:MEDP) Shares Gap DownTime to Sell? - MarketBeat
Medpace Holdings Inc (MEDP) Shares Down 16.15% on Feb 10 - GuruFocus
Medpace (MEDP) Shares Drop Despite Beating Q4 Expectations - GuruFocus
Medpace slumps after Q4 earnings on book-to-bill ratio (MEDP:NASDAQ) - Seeking Alpha
Earnings call transcript: Medpace Q4 2025 beats expectations, stock drops By Investing.com - Investing.com South Africa
Earnings call transcript: Medpace Q4 2025 beats expectations, stock drops - Investing.com
Envestnet Asset Management Inc. Grows Stock Holdings in Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace Holdings revenue up 32.0% to USD 708.5M in Q4 2025 - Medical Buyer
Medpace Holdings: Great Quarter, Stale Backlog, Full Valuation (NASDAQ:MEDP) - Seeking Alpha
Medpace Holdings, Inc. Q4 Income Advances, Beats Estimates - Nasdaq
Finanzdaten der Medpace Holdings Inc-Aktie (MEDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):